Record overview
Status and phase
Status: COMPLETED
Phase: PHASE2
Sponsor: M.D. Anderson Cancer Center
Condition: Head and Neck Cancer, Squamous Cell Cancer
NCT00485485
Imatinib Mesylate (Gleevec) and Docetaxel in Patients With Head and Neck Squamous Cell Cancer
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: stale_update_signal
Results signal: Low Signal
Operational burden: rare_population_signal
Stopped reason
Context when available
No stop reason available in the current public record.